M. Versiani et al., SOCIAL PHOBIA - LONG-TERM TREATMENT OUTCOME AND PREDICTION OF RESPONSE - A MOCLOBEMIDE STUDY, International clinical psychopharmacology, 12(5), 1997, pp. 239-254
In this open, prospective, structured, naturalistic study of the effic
acy of long-term treatment in social phobia 93 consecutive outpatients
suffering from severe generalized or circumscribed social phobia (med
ian Liebowitz Social Anxiety Scale score 83) and a high degree of conc
omitant psychiatric disease were administered treatment with moclobemi
de (712 +/- 75 mg/day at steady state). Fifty-nine patients who respon
ded (Clinical Global Impression for Change: very much/much improved) c
ompleted 2 years of treatment. Patients then entered a drug-free perio
d of at least 1 month during which 88% of the patients deteriorated. I
n a further 2-year treatment period with moclobemide those patients wh
o had deteriorated became responders again. Symptoms recurred in a sub
stantial number of the patients at the end of the study when the dose
was reduced and then discontinued. Post-study follow up at 6-24 months
after study completion found that 63.2% of patients were almost asymp
tomatic or had only mild symptoms, 15.8% were off all treatment, 28.1%
were back on moclobemide, 10.6% were taking another psychotropic drug
and 8.8% were in psychotherapy. All previous non-responders to moclob
emide and mostly alcohol abusers (36.9%), had moderate or severe socia
l phobia and were off all treatment (13.3%), on psychotherapy (15.9%)
or on another psychotropic drug (8.8%). Discriminant analysis correctl
y predicted outcome in 93.5% of all patients. Alcohol abuse was by far
the strongest predictor of negative outcome. Coexisting generalized a
nxiety disorder and dysthymia were less potent in this regard, whereas
high baseline Hamilton anxiety or depression scale scores, circumscri
bed social phobia, or social phobia unassociated with avoidant persona
lity disorder were predictors of a positive outcome. In conclusion, se
vere social phobia can be successfully treated in the long-term but ma
ny patients may need medication or psychotherapy for many years. Treat
ment should start as early as possible because complications such as a
lcohol abuse make treatment difficult.